A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure

PHASE2CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

April 25, 2017

Study Completion Date

June 26, 2017

Conditions
PrehypertensionHypertension, Stage I
Interventions
BIOLOGICAL

B244

odorless suspension

BIOLOGICAL

Vehicle

odorless suspension

Trial Locations (10)

10459

CHEAR Center, The Bronx

20190

Alternative Primary Care (Einstein Clinical Research), Silver Spring

33012

AGA Clinical Trials, Hialeah

35205

Central Research Associates, Birmingham

60611

ICCT Research International, Chicago

70006

MedPharmics, Metairie

77338

Research Trials WorldWide, Humble

85018

Elite Clinical Studies, Phoenix

92780

Orange County Research Center, Tustin

06460

Clinical Research Consulting, Milford

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Veristat, Inc.

OTHER

lead

AOBiome LLC

INDUSTRY